Skip to main content
Top
Published in: Journal of the International AIDS Society 1/2011

Open Access 01-12-2011 | Research

Trends in detectable viral load by calendar year in the Australian HIV observational database

Authors: Matthew G Law, Ian Woolley, David J Templeton, Norm Roth, John Chuah, Brian Mulhall, Peter Canavan, Hamish McManus, David A Cooper, Kathy Petoumenos, The Australian HIV Observational Database (AHOD)

Published in: Journal of the International AIDS Society | Issue 1/2011

Login to get access

Abstract

Background

Recent papers have suggested that expanded combination antiretroviral treatment (cART) through lower viral load may be a strategy to reduce HIV transmission at a population level. We assessed calendar trends in detectable viral load in patients recruited to the Australian HIV Observational Database who were receiving cART.

Methods

Patients were included in analyses if they had started cART (defined as three or more antiretrovirals) and had at least one viral load assessment after 1 January 1997. We analyzed detectable viral load (>400 copies/ml) in the first and second six months of each calendar year while receiving cART. Repeated measures logistic regression methods were used to account for within and between patient variability. Rates of detectable viral load were predicted allowing for patients lost to follow up.

Results

Analyses were based on 2439 patients and 31,339 viral load assessments between 1 January 1997 and 31 March 2009. Observed detectable viral load in patients receiving cART declined to 5.3% in the first half of 2009. Predicted detectable viral load based on multivariate models, allowing for patient loss to follow up, also declined over time, but at higher levels, to 13.8% in 2009.

Conclusions

Predicted detectable viral load in Australian HIV Observational Database patients receiving cART declined over calendar time, albeit at higher levels than observed. However, over this period, HIV diagnoses and estimated HIV incidence increased in Australia.
Literature
1.
go back to reference Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Move J, Hanson C, Zorrilla C, Lew JF: Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. NEJM 1999, 341: 394–402.PubMedCrossRef Garcia PM, Kalish LA, Pitt J, Minkoff H, Quinn TC, Burchett SK, Kornegay J, Jackson B, Move J, Hanson C, Zorrilla C, Lew JF: Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. NEJM 1999, 341: 394–402.PubMedCrossRef
2.
go back to reference Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC, the Rakai Project Team: Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357: 1149–1153.PubMedCrossRef Gray RH, Wawer MJ, Brookmeyer R, Sewankambo NK, Serwadda D, Wabwire-Mangen F, Lutalo T, Li X, vanCott T, Quinn TC, the Rakai Project Team: Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 2001, 357: 1149–1153.PubMedCrossRef
3.
go back to reference Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. JID 2005, 191: 1403–1409.PubMedCrossRef Wawer MJ, Gray RH, Sewankambo NK, Serwadda D, Li X, Laeyendecker O, Kiwanuka N, Kigozi G, Kiddugavu M, Lutalo T, Nalugoda F, Wabwire-Mangen F, Meehan MP, Quinn TC: Rates of HIV-1 transmission per coital act, by stage of HIV-1 infection, in Rakai, Uganda. JID 2005, 191: 1403–1409.PubMedCrossRef
4.
go back to reference Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, Colfax GN: Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 2010, 5: e11068.PubMedCrossRef Das M, Chu PL, Santos GM, Scheer S, Vittinghoff E, McFarland W, Colfax GN: Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS ONE 2010, 5: e11068.PubMedCrossRef
5.
go back to reference Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, Kerr T, Shannon K, Harrigan PR, Hogg RS, Daly P, Kendall P: Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010, 376: 532–539.PubMedCrossRef Montaner JSG, Lima VD, Barrios R, Yip B, Wood E, Kerr T, Shannon K, Harrigan PR, Hogg RS, Daly P, Kendall P: Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet 2010, 376: 532–539.PubMedCrossRef
6.
go back to reference Fang CT, Hsu HM, Twu SJ, Chen MY, Chang YY, Hwang JS, Wang JD, Chuang C-Y, the Division of AIDS and STD, Center for Disease Control, Department of Health, Yuan Executive: Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. JID 2004, 190: 879–885.PubMedCrossRef Fang CT, Hsu HM, Twu SJ, Chen MY, Chang YY, Hwang JS, Wang JD, Chuang C-Y, the Division of AIDS and STD, Center for Disease Control, Department of Health, Yuan Executive: Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. JID 2004, 190: 879–885.PubMedCrossRef
7.
go back to reference Montaner JSG, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006, 368: 531–536.PubMedCrossRef Montaner JSG, Hogg R, Wood E, Kerr T, Tyndall M, Levy AR, Harrigan PR: The case for expanding access to highly active antiretroviral therapy to curb the growth of the HIV epidemic. Lancet 2006, 368: 531–536.PubMedCrossRef
8.
go back to reference Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373: 48–57.PubMedCrossRef Granich RM, Gilks CF, Dye C, De Cock KM, Williams BG: Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 2009, 373: 48–57.PubMedCrossRef
9.
go back to reference Law MG, Prestage G, Grulich AE, Van de Ven P, Kippax S: Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 2001, 15: 1287–1294.PubMedCrossRef Law MG, Prestage G, Grulich AE, Van de Ven P, Kippax S: Modelling the effect of combination antiretroviral treatments on HIV incidence. AIDS 2001, 15: 1287–1294.PubMedCrossRef
10.
go back to reference Clements M, Prestage G, Grulich A, Van de Ven P, Kippax S, Law MG: Modelling trends in HIV incidence among homosexual men in Australia 1995 to 2006. JAIDS 2004, 35: 401–406.PubMedCrossRef Clements M, Prestage G, Grulich A, Van de Ven P, Kippax S, Law MG: Modelling trends in HIV incidence among homosexual men in Australia 1995 to 2006. JAIDS 2004, 35: 401–406.PubMedCrossRef
11.
go back to reference Hoare A, Wilson DP, Regan DG, Kaldor J, Law MG: Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infections. Sexual Health 2008, 5: 1–11.CrossRef Hoare A, Wilson DP, Regan DG, Kaldor J, Law MG: Using mathematical modelling to help explain the differential increase in HIV incidence in New South Wales, Victoria and Queensland: importance of other sexually transmissible infections. Sexual Health 2008, 5: 1–11.CrossRef
12.
go back to reference The Australian HIV Observational Database: Rates of change of combination antiretroviral treatment in Australia. HIV Med 2002, 3: 28–36.CrossRef The Australian HIV Observational Database: Rates of change of combination antiretroviral treatment in Australia. HIV Med 2002, 3: 28–36.CrossRef
14.
go back to reference Wilson DP, Hoare A, Regan DG, Law MG: Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sexual Health 2009, 6: 19–33.PubMedCrossRef Wilson DP, Hoare A, Regan DG, Law MG: Importance of promoting HIV testing for preventing secondary transmissions: modelling the Australian HIV epidemic among men who have sex with men. Sexual Health 2009, 6: 19–33.PubMedCrossRef
15.
16.
go back to reference Prestage G, Jin F, Zablotska IB, Imrie J, Grulich AE, Pitts M: Trends in HIV testing among homosexual and bisexual men in eastern Australian states. Sexual Health 2008, 5: 119–123.PubMedCrossRef Prestage G, Jin F, Zablotska IB, Imrie J, Grulich AE, Pitts M: Trends in HIV testing among homosexual and bisexual men in eastern Australian states. Sexual Health 2008, 5: 119–123.PubMedCrossRef
17.
go back to reference Falster K, Gelgor L, Shaik A, Zablotska I, Prestage G, Grierson J, Thorpe R, Pitts M, Anderson J, Chuah J, Mulhall B, Petoumenso K, Kelleher A, Law MG: Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment. Sexual Health 2008, 5: 141–154.PubMedCrossRef Falster K, Gelgor L, Shaik A, Zablotska I, Prestage G, Grierson J, Thorpe R, Pitts M, Anderson J, Chuah J, Mulhall B, Petoumenso K, Kelleher A, Law MG: Trends in antiretroviral treatment use and treatment response in three Australian states in the first decade of combination antiretroviral treatment. Sexual Health 2008, 5: 141–154.PubMedCrossRef
18.
go back to reference Wand H, Wilson D, Yan P, Gonnermann A, McDonald A, Kaldor J, Law M: Characterising trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method. J Int AIDS Soc 2009, 12 (1) : 19.PubMedCrossRef Wand H, Wilson D, Yan P, Gonnermann A, McDonald A, Kaldor J, Law M: Characterising trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back-projection method. J Int AIDS Soc 2009, 12 (1) : 19.PubMedCrossRef
Metadata
Title
Trends in detectable viral load by calendar year in the Australian HIV observational database
Authors
Matthew G Law
Ian Woolley
David J Templeton
Norm Roth
John Chuah
Brian Mulhall
Peter Canavan
Hamish McManus
David A Cooper
Kathy Petoumenos
The Australian HIV Observational Database (AHOD)
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Journal of the International AIDS Society / Issue 1/2011
Electronic ISSN: 1758-2652
DOI
https://doi.org/10.1186/1758-2652-14-10

Other articles of this Issue 1/2011

Journal of the International AIDS Society 1/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.